Category:Preclinical drug evaluation

**pre-clinical development**
	preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications
	Upload media
	Wikipedia
Instance of	phase of clinical research;
Subclass of	clinical research;
Part of	drug development (phase of clinical research);
Followed by	phase I clinical trial; clinical trial;
Authority file
	Q7239206;
	Reasonator; Scholia; Wikidocumentaries; PetScan; statistics; WikiMap; Locator tool; KML file; Search depicted;

Media in category "Preclinical drug evaluation"

The following 48 files are in this category, out of 48 total.

A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s005.ogv 33 s, 800 × 400; 9.71 MB
A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s006.ogv 33 s, 800 × 400; 8.65 MB
A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s007.ogv 33 s, 800 × 400; 8.83 MB
A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s008.ogv 33 s, 800 × 400; 8.07 MB
A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s009.ogv 33 s, 800 × 400; 7.89 MB
A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s010.ogv 33 s, 800 × 400; 8.74 MB
A-Cell-Based-Small-Molecule-Screening-Method-for-Identifying-Inhibitors-of-Epithelial-Mesenchymal-pone.0033183.s011.ogv 33 s, 800 × 400; 7.34 MB
A-chimeolysin-with-extended-spectrum-streptococcal-host-range-found-by-an-induced-lysis-based-rapid-srep17257-s1.ogv 3.5 s, 211 × 235; 173 KB
A-chimeolysin-with-extended-spectrum-streptococcal-host-range-found-by-an-induced-lysis-based-rapid-srep17257-s2.ogv 3.5 s, 211 × 235; 159 KB
A-high-throughput-chemically-induced-inflammation-assay-in-zebrafish-1741-7007-8-151-S2.ogv 14 s, 1,300 × 1,030; 1.43 MB
A-high-throughput-chemically-induced-inflammation-assay-in-zebrafish-1741-7007-8-151-S3.ogv 15 s, 512 × 512; 978 KB
A-High-Throughput-Screen-for-Tuberculosis-Progression-pone.0016779.s004.ogv 1 min 12 s, 1,024 × 394; 3.55 MB
Development-and-Validation-of-an-Automated-High-Throughput-System-for-Zebrafish-In-Vivo-Screenings-pone.0036690.s005.ogv 15 s, 224 × 224; 487 KB
Development-and-Validation-of-an-Automated-High-Throughput-System-for-Zebrafish-In-Vivo-Screenings-pone.0036690.s006.ogv 15 s, 224 × 224; 367 KB
Development-and-Validation-of-an-Automated-High-Throughput-System-for-Zebrafish-In-Vivo-Screenings-pone.0036690.s007.ogv 15 s, 224 × 224; 311 KB
Development-and-Validation-of-an-Automated-High-Throughput-System-for-Zebrafish-In-Vivo-Screenings-pone.0036690.s008.ogv 15 s, 224 × 224; 313 KB
Development-and-Validation-of-an-Automated-High-Throughput-System-for-Zebrafish-In-Vivo-Screenings-pone.0036690.s009.ogv 15 s, 224 × 224; 210 KB
Drug-Discovery-for-Schistosomiasis-Hit-and-Lead-Compounds-Identified-in-a-Library-of-Known-Drugs-by-pntd.0000478.s005.ogv 11 s, 320 × 240; 639 KB
Drug-Discovery-for-Schistosomiasis-Hit-and-Lead-Compounds-Identified-in-a-Library-of-Known-Drugs-by-pntd.0000478.s006.ogv 13 s, 320 × 240; 294 KB
Human-Engineered-Heart-Tissue-as-a-Versatile-Tool-in-Basic-Research-and-Preclinical-Toxicology-pone.0026397.s004.ogv 14 s, 720 × 576; 1.65 MB
Human-Engineered-Heart-Tissue-as-a-Versatile-Tool-in-Basic-Research-and-Preclinical-Toxicology-pone.0026397.s005.ogv 1 min 0 s, 640 × 480; 1.22 MB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s1.ogv 6.7 s, 364 × 220; 933 KB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s2.ogv 2.3 s, 672 × 308; 271 KB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s3.ogv 27 s, 668 × 288; 13.99 MB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s4.ogv 13 s, 936 × 336; 666 KB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s5.ogv 27 s, 636 × 276; 5.18 MB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s6.ogv 27 s, 636 × 276; 5.16 MB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s7.ogv 27 s, 360 × 260; 2.24 MB
Human-iPSC-based-Cardiac-Microphysiological-System-For-Drug-Screening-Applications-srep08883-s8.ogv 27 s, 340 × 260; 1.4 MB
Impulsiveness-overactivity-and-poorer-sustained-attention-improve-by-chronic-treatment-with-low-1744-9081-7-6-S1.ogv 37 s, 640 × 480; 14.09 MB
Impulsiveness-overactivity-and-poorer-sustained-attention-improve-by-chronic-treatment-with-low-1744-9081-7-6-S2.ogv 31 s, 640 × 480; 11.17 MB
Nanoparticle-Induced-Cell-Magneto-Rotation-Monitoring-Morphology-Stress-and-Drug-Sensitivity-of-a-pone.0028475.s007.ogv 13 s, 160 × 140; 151 KB
Nanoparticle-Induced-Cell-Magneto-Rotation-Monitoring-Morphology-Stress-and-Drug-Sensitivity-of-a-pone.0028475.s008.ogv 26 s, 266 × 199; 331 KB
Nanoparticle-Induced-Cell-Magneto-Rotation-Monitoring-Morphology-Stress-and-Drug-Sensitivity-of-a-pone.0028475.s009.ogv 2 min 0 s, 58 × 54; 194 KB
Non-Metabolic-Membrane-Tubulation-and-Permeability-Induced-by-Bioactive-Peptides-pone.0000201.s001.ogv 3.4 s, 336 × 381; 405 KB
Non-Metabolic-Membrane-Tubulation-and-Permeability-Induced-by-Bioactive-Peptides-pone.0000201.s002.ogv 3.1 s, 350 × 387; 287 KB
Non-Metabolic-Membrane-Tubulation-and-Permeability-Induced-by-Bioactive-Peptides-pone.0000201.s003.ogv 5.7 s, 350 × 331; 259 KB
Non-Metabolic-Membrane-Tubulation-and-Permeability-Induced-by-Bioactive-Peptides-pone.0000201.s004.ogv 5.7 s, 350 × 493; 352 KB
Non-Metabolic-Membrane-Tubulation-and-Permeability-Induced-by-Bioactive-Peptides-pone.0000201.s005.ogv 6.0 s, 391 × 291; 471 KB
Proposed positioning of the Liver-Chip within a typical pharma preclinical workflow.webp 2,048 × 820; 78 KB
Small-molecule-screening-platform-for-assessment-of-cardiovascular-toxicity-on-adult-zebrafish-heart-1472-6793-12-3-S2.ogv 1 min 32 s, 245 × 226; 3.05 MB
Small-molecule-screening-platform-for-assessment-of-cardiovascular-toxicity-on-adult-zebrafish-heart-1472-6793-12-3-S3.ogv 1 min 38 s, 240 × 242; 2.56 MB
WormAssay-A-Novel-Computer-Application-for-Whole-Plate-Motion-based-Screening-of-Macroscopic-pntd.0001494.s001.ogv 1 min 15 s, 1,328 × 816; 39.06 MB
WormAssay-A-Novel-Computer-Application-for-Whole-Plate-Motion-based-Screening-of-Macroscopic-pntd.0001494.s002.ogv 59 s, 1,765 × 1,080; 25.94 MB
WormAssay-A-Novel-Computer-Application-for-Whole-Plate-Motion-based-Screening-of-Macroscopic-pntd.0001494.s003.ogv 49 s, 1,328 × 816; 25.81 MB
WormAssay-A-Novel-Computer-Application-for-Whole-Plate-Motion-based-Screening-of-Macroscopic-pntd.0001494.s004.ogv 1 min 14 s, 1,904 × 1,072; 53.23 MB
WormAssay-A-Novel-Computer-Application-for-Whole-Plate-Motion-based-Screening-of-Macroscopic-pntd.0001494.s005.ogv 58 s, 1,888 × 1,072; 39.27 MB
WormAssay-A-Novel-Computer-Application-for-Whole-Plate-Motion-based-Screening-of-Macroscopic-pntd.0001494.s006.ogv 49 s, 1,872 × 1,072; 34.6 MB

Category:Preclinical drug evaluation

Media in category "Preclinical drug evaluation"

Navigation menu

Search